Global analysis of clinical trials with probiotics

被引：67
|
作者：
Dronkers, Theresia M. G. [1 ]
Ouwehand, Arthur C. [3 ]
Rijkers, Ger T. [1 ,2 ]
机构：
[1] Univ Coll Roosevelt, Dept Sci, Lange Noordstr 1, NL-4331 CB Middelburg, Netherlands
[2] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands
[3] Danisco Sweeteners Oy, DuPont Nutr & Biosci, Kantvik 02460, Finland
来源：
HELIYON | 2020年 / 6卷 / 07期
关键词：
Prebiotics; Probiotics; Bacteria; Microorganism; Digestive system; Immunology; Immune system; Microbiota; Clinical trials; STATEMENT;
D O I：
10.1016/j.heliyon.2020.e04467
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Over 1,000 clinical studies with probiotics, registered at ClinicalTrials.gov and/or the International Clinical Trials Registry Platform (ICTRP) of the World Health Organization, have addressed over 700 different diseases and conditions. The average size of a clinical trial with probiotics (74 participants) is comparable to the overall average of all studies in ClincialTrials.gov. Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis ssp. lactis BB12 are the probiotic strains studied most. The exact composition of the product which is used, including the dosage, is not always indicated in the registry. The majority of probiotics studies at ClinicalTrials.gov is registered in the USA or Europe (56%). The data from ICTRP show the rapid expansion of clinical studies with probiotics in Asia, notably Iran and China.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Data on global analysis of clinical trials with probiotics
    Dronkers, Theresia M. G.
    Ouwehand, Arthur C.
    Rijkers, Ger T.
    DATA IN BRIEF, 2020, 32
  • [2] Clinical trials of probiotics: Current outlook
    Al-Madhagi, Haitham
    Alramo, Abir
    FOOD SCIENCE & NUTRITION, 2024, 12 (03): : 2192 - 2194
  • [3] Safety of meloxicam: A global analysis of clinical trials
    Fenn, GC
    Morant, SV
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (07): : 817 - 818
  • [4] Safety of meloxicam: A global analysis of clinical trials
    Distel, M
    Mueller, C
    Bluhmki, E
    Fries, J
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 : 68 - 77
  • [5] Foreword - Increase in clinical trials for probiotics and prebiotics
    Venema, Koen
    BENEFICIAL MICROBES, 2018, 9 (01) : 1 - 2
  • [6] Bacterial vaginosis: a review on clinical trials with probiotics
    Mastromarino, Paola
    Vitali, Beatrice
    Mosca, Luciana
    NEW MICROBIOLOGICA, 2013, 36 (03): : 229 - 238
  • [7] The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials
    Milajerdi, Alireza
    Mousavi, Seyyed Mohammad
    Sadeghi, Alireza
    Salari-Moghaddam, Asma
    Parohan, Mohammad
    Larijani, Bagher
    Esmaillzadeh, Ahmad
    EUROPEAN JOURNAL OF NUTRITION, 2020, 59 (02) : 633 - 649
  • [8] The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials
    Alireza Milajerdi
    Seyyed Mohammad Mousavi
    Alireza Sadeghi
    Asma Salari-Moghaddam
    Mohammad Parohan
    Bagher Larijani
    Ahmad Esmaillzadeh
    European Journal of Nutrition, 2020, 59 : 633 - 649
  • [9] META-ANALYSIS ON THE EFFECT OF PROBIOTICS ON NEURODEGENERATIVE DISORDERS IN HUMANS CLINICAL TRIALS
    Meng, Henry Yue Hong
    Mak, Chi Hang Christopher
    Mak, Joyce Wing Yan
    Ko, Owen Ho
    Tao, Zuo
    Chan, Francis Ka Leung
    GUT, 2020, 69 : A63 - A64
  • [10] Safety of meloxicam: A global analysis of clinical trials - Reply
    Distel, M
    Bluhmki, E
    Muller, C
    Fries, JF
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (07): : 818 - 819
12345